Cargando…
In vivo anticancer activity of a rhodium metalloinsertor in the HCT116 xenograft tumor model
Mismatch repair (MMR) deficiencies are a hallmark of various cancers causing accumulation of DNA mutations and mismatches, which often results in chemotherapy resistance. Metalloinsertor complexes, including [Rh(chrysi)(phen)(PPO)]Cl(2) (Rh-PPO), specifically target DNA mismatches and selectively in...
Autores principales: | Threatt, Stephanie D., Synold, Timothy W., Wu, Jun, Barton, Jacqueline K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395490/ https://www.ncbi.nlm.nih.gov/pubmed/32661159 http://dx.doi.org/10.1073/pnas.2006569117 |
Ejemplares similares
-
An Unusual
Ligand Coordination Gives Rise to a New
Family of Rhodium Metalloinsertors with Improved Selectivity and Potency
por: Komor, Alexis C., et al.
Publicado: (2014) -
Construction and Application of a Rh–Pt DNA
Metalloinsertor Conjugate
por: Weidmann, Alyson G., et al.
Publicado: (2014) -
A zebrafish HCT116 xenograft model to predict anandamide outcomes on colorectal cancer
por: Maradonna, Francesca, et al.
Publicado: (2022) -
The Effect of Dynamic, In Vivo-like Oxaliplatin on HCT116 Spheroids in a Cancer-on-Chip Model Is Representative of the Response in Xenografts
por: Komen, Job, et al.
Publicado: (2022) -
Curcumin-Free Turmeric Exhibits Activity against Human HCT-116 Colon Tumor Xenograft: Comparison with Curcumin and Whole Turmeric
por: Prasad, Sahdeo, et al.
Publicado: (2017)